Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.7B | 7.4B | 7.7B | 6.8B |
Cost of revenue | 4.6B | 3.7B | 3.8B | 3.4B |
Gross profit | 3.1B | 3.7B | 3.9B | 3.4B |
Operating expense | ||||
Research & development | 1.9B | 1.7B | 1.7B | 1.6B |
Selling general and admin | 991M | 886M | 792M | 721M |
Other operating expenses | — | — | -11M | -14M |
Operating income | -134M | 806M | 1.1B | 724M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 38M | 20M | 19M | 23M |
Other income expense | 98M | 39M | -331M | 36M |
Pretax income | -74M | 825M | 889M | 737M |
Tax provision | -834M | 123M | 419M | -27M |
Net income | 872M | 709M | 482M | 771M |
Basic EPS | 0.5 | 0.4 | 0.3 | 0.5 |
Diluted EPS | 0.5 | 0.4 | 0.3 | 0.5 |
Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
EBITDA | 721M | 1.6B | 1.7B | 1.6B |
Net income from continuing op. | 768M | 709M | 482M | 771M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |